1CHAMPLIN R E,SCHMITZ N, HOROWITZ M M, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation[J]. Blood, 2000,95 : 3702 - 3709.
2ANTIN J H, CHILDS R, FILIPOVICH A H, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohemtopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meeting of the International Bone Marrow Trans plant Registry and the American Society of Blood and Marrow Transplantation [J]. Biot Blood Marrow Transplant, 2001,7 : 473- 485.
3DUBOUSKY J, DAXBERGER W, FRITSCH G, et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non- malignant hematologic disorders: implications for timely detection of engraftment,graft failure and rejection[J]. Leukemia, 1999,13 : 2059 - 2069.
4SCHAAP N, SCHATTENBERG A, MENSINK E, et al. Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation[J]. Leukemia, 2002,16 : 13 - 21.
5FOMANKOVA R, HONZATKOVA L, MORAVCO- VA J, et al. Prediction and reversion of post transplant relapse in patients with chronic myeloid leukemia using mixed chimerism and residual disease detection and adoptive immunotherapy[J]. Leuk Res, 2000,24: 339-347.
6THIEDE C, BORNHAUSER M, OELSCHLAGEL U, et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat markers[J]. Leukemia, 2001,15 : 293- 302.
8PEGGS K S, THOMSON K, HART D P, et al. Doseescalated donor lymphocyte infusions following reduced intersity transplantation: toxicity, chimerism, and disease responses[J]. Blood, 2004, 103: 1548- 1556.
9MARKS D,LUSH R,CAVENAGH J,et al. The toxicity and efficacy of donor lymphocyte infusions given after reduced intensity conditioning allogeneic stem cell transplantation[J]. Blood,2002,100:3108-3114.
10JAKSCH M, UZUNEL M, REMBERGER M, et al. Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades Ⅱ-Ⅳ[J]. Clin Transplant, 2005,19 : 346- 349.
二级参考文献19
1Keil F, Prinz E, Moser K, et al. Rapid establishment of long-term euhure-initiating cells of donor origin after nonmyeloablative allogeneie hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell ehimerism on stable engraftment and progression free survival. Transplantation, 2003, 76:230-236.
2Mattsson J, Uzunel M, Remberger M. et al. T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation. Transplantation,2001, 71:433-439.
3Childs R, Clave E, Contentin N, et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell Chimerism precedes alloimmune response. Blood, 1999, 94:3234-3241.
4Bader P, Stoll K, Huber S, et al. Characterization of lineage-specific chimaerism in patients with acute leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse. Br J Haematol, 2000, 108:761-768.
5Maris M, Niederwieser D, Sandmaier B, et al. HLA-matched unrelated donor hematopoietic cell transplantation after non-myeloablative conditioning for patients with hematologic malignancies. Blood, 2003, 102:2021-2030.
6McSweeney P, Niederwieser D, Shizuru J, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high dose cytotoxic therapy with graft-versus-tumor effects. Blood, 2001,97:3390-3400.
7Gyger M, Baron C, Forest L, et al. Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs-host disease. Exp Hematol, 1998, 26:426-434.
8Mattsson J, Uzunel M, Brune M, et al. Mixed chimaerism is common at time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol, 2001, 115:935-944.
9Thiede C, Lion T. Quantitative analysis of chimerism after allogeneic stem cell transplantation using multiplex PCR amplification of short tantem repeat-markers and fluorescence detection. Leukemia, 2001, 15 : 303 - 306.
10Wekerle T,Sykes M.Mixed chimerism and transplantation tolerance.Ann Rev Med,2001,52:353-370.
4THIEDE C,FLOREK M,BORNHA M,et al.Rapid quantification of mixedchimerism using multiplex amplification of short tandem repeat markers and fluorescence detection[J].Bone Marrow Transpl,1999,23:1055-1060.
5MAURY S,JOUAULT H,KUENTZ M,et al.Chimerism analysis by lineage-specific fluorescent polymerase chain reaction in secondary graft failure after alloeneic stem cell transplantation[J].Transplantation,2001,71:375-380.
6PINDOLIA K,JANAKIRAMAN N,KASTEN-SPORTES C,et al.Enhanced assessment of allogeneic bone marrow transplant engraftment using automated fluorescent-based typing[J].Bone Marrow Transpl,1999,24:1235-1241.
7ANTIN J H,CHILDS R,FILIPOVICH A H,et al.Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation:recommendation from a workshopat the 2001 Tandem Meeting of the Intemational Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation[J].Biol Blood Marrow Transplant,2001,7:473-485.
8RUIZA S,CHAUFFAILLE M L,ALVES S T,et al.Prevalence of chimerism after non-myeloablative hematopoietic stem cell transplantation[J].Sao Paulo Med J,2009,127(5):251-258.
9de WEGER R,TILANUS M,SCHEIDEL K,et al.Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimerism analysis with short tandem repeats[J].Br J Haem,2000,110:647-653.
10DUBOVSKY J,DAXBERGER H,FRITSC H,et al.Kinetics of chimerism during the early post-transplant period in pediatricpatients with malignant and non-malignant hematologic disorders implications for timely detection of engraftment,graft failure and rejection[J].Leukemia,1999,13(12):2060-2069.
